Trials

University Hospitals Birmingham NHS Foundation Trust is a regional and national centre for specialist clinical services.

It is home to some of the country’s leading clinical research institutions, and is dedicated to developing and implementing groundbreaking treatments, technologies and techniques.

  • Mammo-50

    Mammographic surveillance in breast cancer patients aged 50 years or older

    View Trial
  • EUROBACT II

    Epidemiology and determinant of outcomes of hospital acquired Blood Stream Infections in the intensive care. (Eurobact II)

    View Trial
  • SUNRRISE Trial

    Single Use Negative pRessure dressing for Reduction In Surgical site infection following Emergency laparotomy – The SUNRRISE Trial

    View Trial
  • PICO ONBOARD

    NPWT Pre-Registration Study: A Prospective Multicentre Trial to assess performance and safety of a single-use
    negative pressure system. PICO ONBOARD

    View Trial
  • AIR

    Airway Intervention Registry (AIR)

    View Trial
  • A Clinical Trial to investigate biomarker effects of pre-surgical treatment with DDR agents in patients with Head and Neck Squamous Cell Carcinoma (HNSCC) who are planned to undergo surgery that is likely to be followed by radiotherapy and/or chemotherapy

    View Trial
  • AC Immune

    A Phase II Double-Blind Randomized Placebo-Controlled Adaptive Design Study to Assess the Safety Tolerability Immunogenicity and Target Engagement of ACI-24 Formulations in Patients with Mild Alzheimer’s Disease

    View Trial
  • EVALUATING THE NET EFFECTS OF EXTENDING THE AGE RANGE FOR BREAST SCREENING IN THE NHS BREAST SCREENING PROGRAMME IN ENGLAND FROM 50-70 YEARS TO 47-73 YEARS

    View Trial
  • GPED

    General Practitioners and Emergency Departments (GPED): Efficient Models of Care

    View Trial
  • ENHANCE

    A 52-week placebo-controlled randomized Phase 3 study to evaluate the safety and efficacy of seladelpar in subjects with primary biliary cholangitis (PBC) and an inadequate response to or an intolerance to ursodeoxycholic acid (UDCA)

    View Trial